MedTrace Logo

Clinical Trials

Showing trials with last updates posted in 2026.

NCT04250545 | ACTIVE_NOT_RECRUITING | PHASE1
22 participants

Testing of the Anti Cancer Drugs CB-839 HCl (Telaglenastat) and MLN0128 (Sapanisertib) in Advanced Stage Non-small Cell Lung Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2020-10-26
Completion:
2025-11-21
Conditions
  • Leptomeningeal Neoplasm
  • Metastatic Lung Non-Small Cell Carcinoma
  • Metastatic Malignant Neoplasm in the Brain
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • Stage IVA Lung Cancer AJCC v8
  • Stage IVB Lung Cancer AJCC v8
Interventions
  • DRUG
Results Available
NCT03935958 | ACTIVE_NOT_RECRUITING | NA
14 participants

Curcumin in Kidney Transplant Recipients

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2019-11-01
Completion:
2023-12-31
Conditions
  • Disorder Related to Renal Transplantation
Interventions
  • DIETARY_SUPPLEMENT
  • OTHER
No Results Yet
NCT03887988 | ACTIVE_NOT_RECRUITING
300 participants

Orbital Fractures Registry

Study Type:
OBSERVATIONAL
Last Updated:
2026-05-26
Start Date:
2019-11-01
Completion:
2026-12-31
Conditions
  • Orbital Fractures
  • Blow Out Fracture of Orbit
Interventions
  • PROCEDURE
  • OTHER
No Results Yet
NCT03866382 | RECRUITING | PHASE2
314 participants

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2019-05-13
Completion:
2027-02-28
Conditions
  • Bladder Adenocarcinoma
  • Bladder Clear Cell Adenocarcinoma
  • Bladder Mixed Adenocarcinoma
  • Bladder Neuroendocrine Carcinoma
  • Bladder Small Cell Neuroendocrine Carcinoma
  • Bladder Squamous Cell Carcinoma
  • Chromophobe Renal Cell Carcinoma
  • Collecting Duct Carcinoma
  • Invasive Bladder Giant Cell Urothelial Carcinoma
  • Invasive Bladder Lymphoepithelioma-Like Carcinoma
  • Invasive Bladder Nested Urothelial Carcinoma
  • Invasive Bladder Plasmacytoid Urothelial Carcinoma
  • Invasive Bladder Sarcomatoid Urothelial Carcinoma
  • Invasive Bladder Urothelial Carcinoma
  • Kidney Medullary Carcinoma
  • Large Cell Neuroendocrine Carcinoma
  • Malignant Testicular Leydig Cell Tumor
  • Malignant Testicular Sertoli Cell Tumor
  • Metastatic Bladder Carcinoma
  • Metastatic Bladder Clear Cell (Glycogen-Rich) Urothelial Carcinoma
  • Metastatic Bladder Giant Cell Urothelial Carcinoma
  • Metastatic Bladder Large Cell Neuroendocrine Carcinoma
  • Metastatic Bladder Lipid-Rich Urothelial Carcinoma
  • Metastatic Bladder Micropapillary Urothelial Carcinoma
  • Metastatic Bladder Plasmacytoid Urothelial Carcinoma
  • Metastatic Bladder Sarcomatoid Urothelial Carcinoma
  • Metastatic Bladder Small Cell Neuroendocrine Carcinoma
  • Metastatic Bladder Squamous Cell Carcinoma
  • Metastatic Chromophobe Renal Cell Carcinoma
  • Metastatic Kidney Medullary Carcinoma
  • Metastatic Malignant Genitourinary System Neoplasm
  • Metastatic Papillary Renal Cell Carcinoma
  • Metastatic Penile Carcinoma
  • Metastatic Prostate Small Cell Neuroendocrine Carcinoma
  • Metastatic Sarcomatoid Renal Cell Carcinoma
  • Metastatic Urethral Carcinoma
  • Papillary Renal Cell Carcinoma
  • Sarcomatoid Renal Cell Carcinoma
  • Stage IV Bladder Cancer AJCC v8
  • Stage IV Penile Cancer AJCC v8
  • Stage IV Renal Cell Cancer AJCC v8
  • Stage IV Urethral Cancer AJCC v8
  • Stage IVB Prostate Cancer AJCC v8
  • Urachal Adenocarcinoma
  • Urethral Clear Cell Adenocarcinoma
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT03820817 | COMPLETED | PHASE1
50 participants

Rifaximin in Patients With Monoclonal Gammopathy

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2019-05-15
Completion:
2025-11-30
Conditions
  • IgA Monoclonal Gammopathy
  • IgG Monoclonal Gammopathy
  • IgM Monoclonal Gammopathy
  • Light Chain Deposition Disease
  • Monoclonal Gammopathy
  • Smoldering Waldenstrom Macroglobulinemia
  • Waldenstrom Macroglobulinemia
  • Gammopathy, Monoclonal
  • Gammopathy Igg
Interventions
  • DRUG
No Results Yet
NCT03604991 | SUSPENDED | PHASE2/PHASE3
278 participants

Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2019-05-03
Completion:
2026-12-31
Conditions
  • Clinical Stage II Esophageal Adenocarcinoma AJCC v8
  • Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Clinical Stage III Esophageal Adenocarcinoma AJCC v8
  • Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8
  • Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Esophageal Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
  • RADIATION
No Results Yet
NCT03598998 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
13 participants

Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2019-02-04
Completion:
2023-05-03
Conditions
  • Anaplastic Large Cell Lymphoma
  • Nodal Peripheral T-Cell Lymphoma With TFH Phenotype
  • Recurrent Anaplastic Large Cell Lymphoma
  • Recurrent Angioimmunoblastic T-Cell Lymphoma
  • Recurrent Enteropathy-Associated T-Cell Lymphoma
  • Recurrent Follicular Lymphoma
  • Recurrent Hepatosplenic T-Cell Lymphoma
  • Recurrent Mature T- Cell and NK-Cell Non-Hodgkin Lymphoma
  • Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
  • Recurrent Mycosis Fungoides
  • Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified
  • Refractory Anaplastic Large Cell Lymphoma
  • Refractory Angioimmunoblastic T-Cell Lymphoma
  • Refractory Enteropathy-Associated T-Cell Lymphoma
  • Refractory Follicular Lymphoma
  • Refractory Hepatosplenic T-Cell Lymphoma
  • Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
  • Refractory Mycosis Fungoides
  • Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified
  • Subcutaneous Panniculitis-Like T-Cell Lymphoma
Interventions
  • BIOLOGICAL
  • DRUG
Results Available
NCT03570827 | COMPLETED | PHASE2
53 participants

Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2018-05-14
Completion:
2025-05-15
Conditions
  • Prostate Adenocarcinoma
  • Stage IIB Prostate Cancer AJCC v8
  • Stage III Prostate Cancer AJCC v8
  • Stage IIIA Prostate Cancer AJCC v8
  • Stage IIIB Prostate Cancer AJCC v8
  • Stage IIIC Prostate Cancer AJCC v8
Interventions
  • RADIATION
  • OTHER
  • DRUG
Results Available
Previous
Sorted by latest updates
Next
Showing 40 trials per page